These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 27892764)

  • 1. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.
    Bryson BL; Junk DJ; Cipriano R; Jackson MW
    Cell Cycle; 2017 Feb; 16(4):319-334. PubMed ID: 27892764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M.
    Kan CE; Cipriano R; Jackson MW
    Cancer Res; 2011 Nov; 71(22):6930-9. PubMed ID: 21975934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.
    Junk DJ; Bryson BL; Smigiel JM; Parameswaran N; Bartel CA; Jackson MW
    Oncogene; 2017 Jul; 36(28):4001-4013. PubMed ID: 28288136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.
    Doherty MR; Parvani JG; Tamagno I; Junk DJ; Bryson BL; Cheon HJ; Stark GR; Jackson MW
    Breast Cancer Res; 2019 Apr; 21(1):54. PubMed ID: 31036052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells.
    Boudreau HE; Casterline BW; Rada B; Korzeniowska A; Leto TL
    Free Radic Biol Med; 2012 Oct; 53(7):1489-99. PubMed ID: 22728268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M activation of Stat3:Smad3 complexes drives senescence.
    La Belle AA; Schiemann WP
    Cell Cycle; 2017 Mar; 16(6):497-498. PubMed ID: 28129030
    [No Abstract]   [Full Text] [Related]  

  • 8. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
    Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
    Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition.
    Reka AK; Kurapati H; Narala VR; Bommer G; Chen J; Standiford TJ; Keshamouni VG
    Mol Cancer Ther; 2010 Dec; 9(12):3221-32. PubMed ID: 21159608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.
    Yu Z; Li Z; Wang C; Pan T; Chang X; Wang X; Zhou Q; Wu X; Li J; Zhang J; Liu B; Zhu Z; Su L
    Gastric Cancer; 2019 Sep; 22(5):955-966. PubMed ID: 30778797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
    Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
    Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo.
    Tiffen PG; Omidvar N; Marquez-Almuina N; Croston D; Watson CJ; Clarkson RW
    Mol Endocrinol; 2008 Dec; 22(12):2677-88. PubMed ID: 18927239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro.
    Takata F; Dohgu S; Matsumoto J; Machida T; Sakaguchi S; Kimura I; Yamauchi A; Kataoka Y
    J Cell Biochem; 2018 Nov; 119(11):9055-9063. PubMed ID: 30076740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls
    Du D; Katsuno Y; Meyer D; Budi EH; Chen SH; Koeppen H; Wang H; Akhurst RJ; Derynck R
    EMBO Rep; 2018 Jan; 19(1):135-155. PubMed ID: 29233829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad3-STAT3 crosstalk in pathophysiological contexts.
    Itoh Y; Saitoh M; Miyazawa K
    Acta Biochim Biophys Sin (Shanghai); 2018 Jan; 50(1):82-90. PubMed ID: 29140406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
    Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M induces tumorigenic properties in non-transformed human prostate epithelial cells, in part through activation of signal transducer and activator of transcription 3 (STAT3).
    Sterbova S; Karlsson T; Persson E
    Biochem Biophys Res Commun; 2018 Apr; 498(4):769-774. PubMed ID: 29526757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression.
    Sarközi R; Hauser C; Noppert SJ; Kronbichler A; Pirklbauer M; Haller VM; Grillari J; Grillari-Voglauer R; Mayer G; Schramek H
    Am J Physiol Renal Physiol; 2011 Nov; 301(5):F1014-25. PubMed ID: 21816755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 and ERK Signaling Pathways Are Implicated in the Invasion Activity by Oncostatin M through Induction of Matrix Metalloproteinases 2 and 9.
    Ko HS; Park BJ; Choi SK; Kang HK; Kim A; Kim HS; Park IY; Shin JC
    Yonsei Med J; 2016 May; 57(3):761-8. PubMed ID: 26996579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.
    Xue J; Lin X; Chiu WT; Chen YH; Yu G; Liu M; Feng XH; Sawaya R; Medema RH; Hung MC; Huang S
    J Clin Invest; 2014 Feb; 124(2):564-79. PubMed ID: 24382352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.